全文获取类型
收费全文 | 6524篇 |
免费 | 429篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 182篇 |
妇产科学 | 311篇 |
基础医学 | 833篇 |
口腔科学 | 113篇 |
临床医学 | 650篇 |
内科学 | 1373篇 |
皮肤病学 | 47篇 |
神经病学 | 1090篇 |
特种医学 | 272篇 |
外科学 | 698篇 |
综合类 | 66篇 |
一般理论 | 1篇 |
预防医学 | 442篇 |
眼科学 | 57篇 |
药学 | 420篇 |
中国医学 | 9篇 |
肿瘤学 | 344篇 |
出版年
2021年 | 101篇 |
2020年 | 44篇 |
2019年 | 70篇 |
2018年 | 107篇 |
2017年 | 60篇 |
2016年 | 60篇 |
2015年 | 97篇 |
2014年 | 139篇 |
2013年 | 189篇 |
2012年 | 296篇 |
2011年 | 305篇 |
2010年 | 186篇 |
2009年 | 181篇 |
2008年 | 285篇 |
2007年 | 274篇 |
2006年 | 272篇 |
2005年 | 276篇 |
2004年 | 250篇 |
2003年 | 233篇 |
2002年 | 236篇 |
2001年 | 193篇 |
2000年 | 195篇 |
1999年 | 157篇 |
1998年 | 66篇 |
1997年 | 64篇 |
1996年 | 46篇 |
1995年 | 62篇 |
1994年 | 75篇 |
1992年 | 170篇 |
1991年 | 155篇 |
1990年 | 146篇 |
1989年 | 161篇 |
1988年 | 153篇 |
1987年 | 166篇 |
1986年 | 140篇 |
1985年 | 133篇 |
1984年 | 112篇 |
1983年 | 82篇 |
1982年 | 64篇 |
1981年 | 52篇 |
1980年 | 53篇 |
1979年 | 103篇 |
1978年 | 68篇 |
1977年 | 51篇 |
1976年 | 58篇 |
1975年 | 53篇 |
1974年 | 49篇 |
1973年 | 53篇 |
1972年 | 65篇 |
1970年 | 43篇 |
排序方式: 共有6960条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Solyakov Lev Dobrota Dušan Drany Oleg Vachova Milena Machač Stanislav Mezešova Viera Bachurin Sergey Lombardi Vincenzo 《Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid》1995,25(2-3):123-134
Molecular and chemical neuropathology - Changes in the functioning of the glutamatergic system in rabbit brain were studied after partial brain ischemia and reperfusion. In vitro studies were... 相似文献
5.
A flow-through finite-dose diffusion cell has been designed for use in transdermal drug delivery research. The diffusion cell consists of an upper donor chamber and a lower receiver compartment through which a continuous supply of fresh solvent flows. The flow is directed to an automatic fraction collector. To validate the flow-through cell, its performance was compared directly against that of a conventional single-reservoir Franz cell. Homologous alkyl p-aminobenzoates were diffused through dimethylpolysiloxane membranes, and permeability coefficients increased with increasing chain length, reaching a plateau at the butyrate ester for both types of cells. This behavior suggests a shift from membrane-controlled diffusion to boundary layer control. Permeation of the butyrate and valerate compounds was significantly faster when the flow-through cell was used, suggesting that better mixing is obtained through the flow-through cell design. Considering the advantages offered in terms of time and labor saved through its use, the flow-through cell with automatic fraction collector appears to be a viable alternative to the conventional Franz cell. 相似文献
6.
Nurse practitioner and physician assistant practices in three HMOs: implications for future US health manpower needs. 下载免费PDF全文
This study empirically examines the practices of non-physician providers (NPPs) within three large competitive health maintenance organizations (HMOs), as well as the physicians' and NPPs' views regarding the ideal role of NPPs. These roles are compared with NPP delegation patterns incorporated in the modeling methodology developed by the Graduate Medical Education National Advisory Committee (GMENAC). GMENAC recommended relatively high levels of delegation by physicians to NPPs. One of the HMO sites made use of NPPs at rates even higher than GMENAC's national ideals, while the rates at the other two were lower. The normative ideals for pediatric NPPs developed at each HMO were consistently higher than their actual roles. Concerns with acceptance and the role of NPPs are clearly no longer issues. Instead, the limits on NPP involvement appear to relate to considerations of costs, availability, and the increasing numbers of physicians competing for similar opportunities. 相似文献
7.
Rats were trained in a Y-maze on a two-choice simultaneous black-white discrimination with either black or white as S+. Animals were then transferred to one of three discrimination tasks. In task 1 (New S–), a new stimulus, either vertical or horizontal stripes, was substituted for the original S–. In task 2 (New S+), a new stimulus, either vertical or horizontal stripes as in task 1, was substituted for the original S+. In task 3 (New S+/S–) animals were trained on horizontal-vertical discrimination. The pre-trial administration of 1 mg/kg d-amphetamine facilitated the acquisition of the original black-white discrimination with both black as S+ and white as S+. Likewise, the drug improved performance in all three transfer conditions. However, the course of learning in the three transfer tasks was different in the placebo- and amphetamine-treated animals. Amphetamine-treated animals were disrupted more by a change in S+ than by a change in S–, whereas the opposite pattern was evident in the placebo controls. When both discriminative stimuli were changed, placebo animals exhibited pronounced decrement in performance, whereas amphetamine animals exhibited excellent learning. The implications of these findings for the effects of amphetamine on discrimination learning are discussed. 相似文献
8.
L J Lesko J R Benotti J S Alpert P M Brady J E McCue B H Weiner I S Ockene 《Journal of pharmaceutical sciences》1986,75(10):952-954
The pharmacokinetics of intravenous bepridil (1-[2-(N-benzylanilino)-1-(isobutoxymethyl)ethyl]pyrrolidine ) were studied in 16 patients undergoing cardiac catheterization for evaluation of coronary disease, all with normal base-line hemodynamic and renal functions. Ten patients received 3 mg/kg and six patients received 4 mg/kg of bepridil infused over a period of 30 min. Plasma bepridil concentrations were measured by HPLC and analyzed by model-dependent and model-independent methods. The mean (+/- SD) maximum plasma bepridil concentrations at the end of the infusion were 2047 +/- 820 ng/mL (3 mg/kg) and 2478 +/- 1426 ng/mL (4 mg/kg). Postinfusion bepridil concentrations were best described by a two-compartment open model. The model-dependent harmonic mean distribution and elimination half-lives were 1.7 h (range: 1.1-2.2 h) and 19.7 h (range: 8.0-61.9 h), respectively. The harmonic mean elimination half-life from model-independent analysis was 14.9 h (range: 7.4-64.0 h). The arithmetic means of other model-independent kinetic parameters were systemic clearance, 0.524 +/- 0.215 L X kg-1 X h-1; Vd, 15.3 +/- 10.9 L/kg; and Vdss, 10.1 +/- 6.0 L/kg. Model-dependent and model-independent estimates of half-life and clearance agreed reasonably well. Bepridil was well tolerated, effecting little or no change in central hemodynamics or EKG intervals. The extensive distribution and relatively slow clearance of bepridil account for its long elimination half-life. Intravenous bepridil appears to be a safe calcium (II) antagonist that is suitable for once-a-day dosing. 相似文献
9.
J.D. Schold T.R. Srinivas G. Guerra A.I. Reed R.J. Johnson I.D. Weiner R. Oberbauer J.S. Harman A.W. Hemming H.U. Meier-Kriesche 《American journal of transplantation》2007,7(3):550-559
Research suggests that end-stage renal disease patients with elevated body mass index (BMI) have superior outcomes on dialysis. In contrast, low and high BMI patients represent the highest risk cohorts for kidney transplant recipients. The important question remains concerning how to manage transplant candidates given the potentially incommensurate impact of BMI by treatment modality. We conducted a retrospective analysis of waitlisted and transplanted patients in the United States from 1990 to 2003. We constructed Cox models to evaluate the effect of BMI on mortality of waitlisted candidates and identified risk factors for rapid weight change. We then assessed the impact of weight change during waitlisting on transplant outcomes. Decline in BMI on the waiting list was not protective for posttransplant mortality or graft loss across BMI strata. Substantial weight loss pretransplantation was associated with rapid gain posttransplantation. The highest risk for death was among listed patients with low BMI (13-20 kg/m(2), adjusted hazard ratio = 1.47, p < 0.01). Approximately one-third of candidates had a change in BMI category prior to transplantation. While observed declines in BMI may be volitional or markers of disease processes, there is no evidence that candidates have improved transplant outcomes attributable to weight loss. Prospective trials are needed to evaluate the efficacy of weight loss protocols for candidates of kidney transplantation. 相似文献
10.